0
Acelyrin, Inc. Banner Image

Acelyrin, Inc.

  • Ticker SLRN
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Acelyrin, Inc. Logo Image
  • 51-200 Employees
  • Based in Agoura Hills, California
ACELYRIN, INC. (Nasdaq: SLRN) is focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating the development and commercialization of transformative medicines. ACELYRIN’s lead program, lonigutamab, is a subcutaneously delivered monoclonal antibody targeting IGF-1R being investigated for the treatment of thyroid eye disease.
REPORT RATINGS
5.0 / 5.0 (1)

Acelyrin, Inc. reports have an aggregate usefulness score of 5.0 based on 1 reviews.

Acelyrin, Inc.

Most Recent Annual Report

Acelyrin, Inc.
MOST RECENT 2023 Annual Report and Form 10K
Acelyrin, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!